The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program

Hemophilia A and B are X-linked diseases that predominantly affect male patients. Patients can develop coagulation factor inhibitors, which exponentially increases the treatment cost. However, the prevalence of factor VIII and IX inhibitors in Saudi Arabia is unclear. This study aimed to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Owaidah, Tarek, Momen, Abdulkareem Al, Alzahrani, Hazzaa, Almusa, Abdulrahman, Alkasim, Fawaz, Tarawah, Ahmed, Nouno, Randa Al, Batniji, Fatima Al, Alothman, Fahad, Alomari, Ali, Abu-Herbish, Saud, Abu-Riash, Mahmoud, Siddiqui, Khawar, Ahmed, Mansor, Mohamed, SY, Saleh, Mahasen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266150/
https://www.ncbi.nlm.nih.gov/pubmed/28079788
http://dx.doi.org/10.1097/MD.0000000000005456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266150/
https://www.ncbi.nlm.nih.gov/pubmed/28079788
http://dx.doi.org/10.1097/MD.0000000000005456

Ejemplares similares